Eli Lilly and Co Newsroom

Barclays Remains a Buy on Eli Lilly & Co (LLY)

TipRanks15:57

Eli Lilly and Co Analyst Ratings

BenzingaJul 5 21:37

Morgan Stanley Maintains Overweight on Eli Lilly and Co, Maintains $1023 Price Target

BenzingaJul 5 21:37

Goldman Sachs raised the target price of Eli Lilly and Co. to $793.

Gelonghui FinanceJul 3 23:23

BMO Capital Maintains Outperform on Eli Lilly and Co, Maintains $1001 Price Target

BenzingaJul 3 20:57

Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating

MT NewswiresJul 3 17:38

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

BenzingaJul 1 23:15

Eli Lilly and Co Analyst Ratings

BenzingaJul 1 23:12

Eli Lilly and Co Analyst Ratings

BenzingaJun 27 00:10

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

BenzingaJun 27 00:09

Jefferies Financial raised the target price of Eli Lilly and Co. to $1015.

Gelonghui FinanceJun 25 17:18

Eli Lilly and Co Analyst Ratings

BenzingaJun 24 22:47

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

BenzingaJun 24 22:46

Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994

MT NewswiresJun 24 18:15

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

BenzingaJun 20 21:12

Eli Lilly and Co Analyst Ratings

BenzingaJun 18 01:25

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

BenzingaJun 18 01:25

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

BenzingaJun 13 00:06

Eli Lilly and Co Analyst Ratings

BenzingaJun 12 00:30

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

BenzingaJun 12 00:28